Twist, Regeneron partner on genetics NGS panel

By The Science Advisory Board staff writers

June 14, 2021 -- Twist Bioscience is collaborating with Regeneron subsidiary Regeneron Genetics Center to launch a custom next-generation sequencing (NGS) population genetics genotyping assay.

The Twist Diversity SNP Panel will help users determine disease mechanisms, identify drug targets, and speed drug development, according to the firm. The panel includes 1.4 million genetic variations called single-nucleotide polymorphisms (SNPs) and is the company's first release in its Targeted Genotyping-By-Sequencing portfolio, Twist said.

Twist said it plans to immediately begin marketing the assay under the Regeneron agreement.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.